Literature DB >> 2723618

Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein.

E A Emini1, V Larson, J Eichberg, P Conard, V M Garsky, D R Lee, R W Ellis, W J Miller, C A Anderson, R J Gerety.   

Abstract

A peptide was synthesized containing the entire 55 amino acid residue sequence of the hepatitis B virus (HBV) surface antigen preS2 region (ad subtype). The unconjugated peptide was inoculated into four chimpanzees. Following multiple injections, all of the animals developed specific antipeptide antibodies that reacted with intact surface antigen particles bearing the preS2 moiety. All four peptide-inoculated animals were found to be protected from infection after intravenous challenge with live HBV of either the ad or ay subtypes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723618     DOI: 10.1002/jmv.1890280103

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Response to hepatitis B vaccination by liver transplant candidates.

Authors:  D H Van Thiel; L el-Ashmawy; K Love; J S Gavaler; T E Starzl
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 2.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

Review 3.  The chimpanzee model for hepatitis B virus infection.

Authors:  Stefan F Wieland
Journal:  Cold Spring Harb Perspect Med       Date:  2015-06-01       Impact factor: 6.915

4.  Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.

Authors:  V Lambert; D Fernholz; R Sprengel; I Fourel; G Deléage; G Wildner; C Peyret; C Trépo; L Cova; H Will
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

Review 5.  The humoral immune response in acute and chronic hepatitis B virus infection.

Authors:  D R Milich; M Sallberg; T Maruyama
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.

Authors:  Wolfram H Gerlich
Journal:  Med Microbiol Immunol       Date:  2014-12-19       Impact factor: 3.402

7.  Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens.

Authors:  C Sureau; A M Moriarty; G B Thornton; R E Lanford
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.